These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 25646742

  • 1. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA, Seibel WL, Kupert E, Hu XX, Potharla VY, Anderson MW.
    Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC, Kuan CP, Lin JY, Lai JS, Ho TF.
    Chem Res Toxicol; 2015 Aug 17; 28(8):1574-83. PubMed ID: 26203587
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 5. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
    Duiker EW, de Vries EG, Mahalingam D, Meersma GJ, Boersma-van Ek W, Hollema H, Lub-de Hooge MN, van Dam GM, Cool RH, Quax WJ, Samali A, van der Zee AG, de Jong S.
    Clin Cancer Res; 2009 Mar 15; 15(6):2048-57. PubMed ID: 19276284
    [Abstract] [Full Text] [Related]

  • 6. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S, Tripathi N, Preet R, Siddharth S, Nayak A, Bharatam PV, Kundu CN.
    Oncotarget; 2017 Jan 03; 8(1):248-267. PubMed ID: 27542249
    [Abstract] [Full Text] [Related]

  • 7. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 8. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY.
    Mol Pharmacol; 2007 Nov 01; 72(5):1269-79. PubMed ID: 17684158
    [Abstract] [Full Text] [Related]

  • 9. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T.
    J Chemother; 2017 Jun 01; 29(3):179-188. PubMed ID: 28067150
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY, Hong M, Heo SH, Park S, Kwon TK, Sung YH, Oh Y, Lee S, Yi GS, Kim I.
    Mol Carcinog; 2018 Nov 01; 57(11):1492-1506. PubMed ID: 29964331
    [Abstract] [Full Text] [Related]

  • 11. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 01; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 12. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H, Bousserouel S, Gossé F, Raul F.
    Apoptosis; 2012 Aug 01; 17(8):797-809. PubMed ID: 22555452
    [Abstract] [Full Text] [Related]

  • 13. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J, Wang Y, Liu L, Yuan Y, Bao Y.
    Zhongguo Fei Ai Za Zhi; 2017 Feb 20; 20(2):80-87. PubMed ID: 28228218
    [Abstract] [Full Text] [Related]

  • 14. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
    Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK.
    Carcinogenesis; 2006 Oct 20; 27(10):2008-17. PubMed ID: 16613838
    [Abstract] [Full Text] [Related]

  • 15. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO, Asami Y, Long H, Jang JH, Bae EY, Kim BY, Choi YH, Kang CH, Ahn JS, Kim GY.
    Toxicol In Vitro; 2013 Feb 20; 27(1):257-63. PubMed ID: 22982206
    [Abstract] [Full Text] [Related]

  • 16. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 20; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 17. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L, Zongyuan Y, Cheng G, Lingyun Z, Guilian Y, Wei G.
    Cancer Sci; 2014 May 20; 105(5):520-7. PubMed ID: 24612139
    [Abstract] [Full Text] [Related]

  • 18. 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5.
    Chen Y, Wei L, Zhang X, Liu X, Chen Y, Zhang S, Zhou L, Li Q, Pan Q, Zhao S, Liu H.
    Oncol Rep; 2018 Nov 20; 40(5):2435-2444. PubMed ID: 30132536
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
    Baritaki S, Huerta-Yepez S, Sakai T, Spandidos DA, Bonavida B.
    Mol Cancer Ther; 2007 Apr 20; 6(4):1387-99. PubMed ID: 17431117
    [Abstract] [Full Text] [Related]

  • 20. Inostamycin enhanced TRAIL-induced apoptosis through DR5 upregulation on the cell surface.
    Yamamoto K, Makino M, Watanapokasin R, Tashiro E, Imoto M.
    J Antibiot (Tokyo); 2012 Jun 20; 65(6):295-300. PubMed ID: 22472572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.